Note: January 16, 2018 CDC Public Health Grand Rounds topic change to: “Public Health Response to Severe Influenza.”
The topic for CDC’s Public Health Grand Rounds on January 16, 2018 will now focus on influenza. With the spike in flu cases around the country, this Grand Rounds will provide key and timely information for public health professionals on how to reduce the spread of seasonal flu in communities and adjust to spot shortages in antiviral drugs because of high influenza activity in some areas.
To date, this influenza season is notable for the sheer volume of flu that most of the United States is seeing at the same time, which can stress health systems. The vast majority of this activity has been caused by influenza A H3N2, associated with severe illness in young children and people 65 years and older.
Join us for this session of Grand Rounds to learn what steps can be taken to reduce the spread of flu in communities and adjust to spot shortages in antiviral drugs in some places experiencing high influenza activity. Contractors may attend this meeting with the prior approval of their employer.
The previous public health topic will be rescheduled for a future Grand Rounds.
CDC’s Public Health Grand Rounds Presents:
“Public Health Response to a Sharp Increase in Severe Seasonal Influenza”
Tuesday, January 16, 2018
1:00 to 2:00 p.m. (ET)
Global Communications Center (Building 19)
Alexander D. Langmuir Auditorium
Roybal Campus
Presented by:
Anne Schuchat, MD (RADM, USPHS)
Principal Deputy Director
Centers for Disease Control and Prevention
“Introduction”
Dan Jernigan, MD, MPH, Captain, USPHS
Director, Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
“Chasing Flu”
David Wentworth, PhD
Chief, Virology, Surveillance, and Diagnosis Branch, Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
“The Problem of H3N2”
Alicia Fry, MD, MPH, Captain, USPHS
Chief, Epidemiology and Prevention Branch, Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
“Mitigating Influenza with Vaccines and Antivirals”
Facilitated By:
John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds
Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds
Susan Laird, MSN, RN, Communications Director, Public Health Grand Rounds
Our sessions are open to the public:
For CDC staff unable to attend in person:
For non-FTE staff who want to attend in person:
Contractors may attend this meeting with the prior approval of their employer.
For non-CDC staff who want to attend in person:
Non-CDC staff must have prior security clearance. US citizens must submit a request to the Grand Rounds Team. A US state-issued photo ID (e.g., driver’s license, US passport) is required.
Non-US citizens must submit their requests 20 days prior to the session to the Grand Rounds Team, and additional information will be required.
For individuals requiring reasonable accommodations:
It is the policy of CDC to provide reasonable accommodations (RA) for qualified individuals with disabilities to ensure their full inclusion in CDC-sponsored events. Employees are asked to submit RA requests at least 5 business days prior to the event. Please e-mail the request.
For questions about this Grand Rounds topic: Feel free to e-mail your questions before or during the session.
CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this activity.
No hay comentarios:
Publicar un comentario